EFFICACY AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ROTATOR CUFF TENDINOPATHY: A 24-WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II PROOF-OF-CONCEPT TRIAL

Millar NL, Mcinnes I, Mindeholm L, Seroutou A, Praestgaard J, Schramm U, Levitch R, Weber E, Laurent D, Rosen J, Schett G, Roubenoff R, Schieker M (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 211-212

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2021-eular.45

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Novartis AG CH Switzerland (CH) University of Glasgow GB United Kingdom (GB) NewYork-Presbyterian Queens US United States (USA) (US)

How to cite

APA:

Millar, N.L., Mcinnes, I., Mindeholm, L., Seroutou, A., Praestgaard, J., Schramm, U.,... Schieker, M. (2021). EFFICACY AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ROTATOR CUFF TENDINOPATHY: A 24-WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II PROOF-OF-CONCEPT TRIAL. In ANNALS OF THE RHEUMATIC DISEASES (pp. 211-212). LONDON: BMJ PUBLISHING GROUP.

MLA:

Millar, N. L., et al. "EFFICACY AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ROTATOR CUFF TENDINOPATHY: A 24-WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II PROOF-OF-CONCEPT TRIAL." Proceedings of the Annual European Congress of Rheumatology (EULAR) LONDON: BMJ PUBLISHING GROUP, 2021. 211-212.

BibTeX: Download